title: Randall E. Morris, MD, FRCP: Stanford University School of Medicine and former Global Head of Transplantation Therapeutic Area (Discovery Research) and Global Head of Transplantation Translational Medicine, Novartis, AG, Basel, Switzerland.
authors: Randall E
authors: RE
authors: Morris
mesh_terms: D002321:Career Choice; D004059:Diffusion of Innovation; D055808:Drug Discovery / Q000639:trends*; D004345:Drug Industry / Q000639:trends*; D005544:Forecasting; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016377:Organ Transplantation / Q000009:adverse effects / Q000639:trends*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents